Jump Financial’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$104K Buy
+11,400
New +$144K ﹤0.01% 1748
2025
Q4
Sell
-12,226
Closed -$266K 1975
2025
Q3
$266K Buy
+12,226
New +$144K ﹤0.01% 1530
2024
Q4
Sell
-24,322
Closed -$273K 1693
2024
Q3
$273K Buy
24,322
+7,376
+44% +$70.6K 0.01% 1352
2024
Q2
$91.3K Buy
+16,946
New +$98.1K ﹤0.01% 1653
2023
Q1
Sell
-14,312
Closed -$121K 1649
2022
Q4
$121K Buy
14,312
+877
+7% +$8.31K 0.01% 1396
2022
Q3
$139K Buy
+13,435
New +$177K 0.01% 1407
2022
Q2
Sell
-15,800
Closed -$164K 1663
2022
Q1
$164K Sell
15,800
-5,600
-26% -$51K 0.01% 1347
2021
Q4
$240K Buy
+21,400
New +$320K 0.02% 1012
2021
Q3
Sell
-17,982
Closed -$343K 1145
2021
Q2
$343K Sell
17,982
-15
-0.1% -$290 0.03% 613
2021
Q1
$380K Buy
+17,997
New +$385K 0.04% 511

Other funds holding CLPT

Jump Financial's CLPT Position: Q1 2026 in Review

Jump Financial opened a new position in ClearPoint Neuro (CLPT) in Q1 2026: 11,400 shares worth $104K. The stake represents ﹤0.01% of the portfolio and ranks #1748 among its holdings. This is a return to the name: Jump Financial previously reported a position in CLPT as recently as Q3 2025.

Jump Financial first reported a position in CLPT in Q1 2021 and has held it in 10 quarters since. The position peaked at $380K in Q1 2021. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Jump Financial held 11,400 shares of ClearPoint Neuro worth $104K as of Q1 2026.
  • ClearPoint Neuro was a new Jump Financial position in Q1 2026.
  • ClearPoint Neuro made up ﹤0.01% of Jump Financial's portfolio in Q1 2026, its #1748 holding.
  • Jump Financial first reported a position in ClearPoint Neuro in Q1 2021 and has held it in 10 quarters since.
  • Jump Financial's ClearPoint Neuro position peaked at $380K in Q1 2021.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.